Pheniramine Maleate

马来酸非尼拉敏

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePheniramine Maleate
Drug Alias Name顺丁烯二酸非尼腊明feniraminapheniraminum马来酸非利拉明马来酸抗感明 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsHypersensitivity
Approved Indications in ChinaHypersensitivity
Original Approved Country/TerritoryMainland China
Original Approved Date2004/09/14
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesShandong Bausch & Lamb Freda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypersensitivity
Inactive IndicationsN/A

Other Information

ATC CodeD04AA16R06AB05
Related LinksWikipediaDrugBankKEGG